Adaltis Developpement inc.
2004 - 2008
Adaltis is an international in-vitro diagnostic company having its headquarters in Montreal, Canada. Adaltis develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases, and measure human hormone responses. Return to the parent company in January 2008.
10900, Hamon Street Montréal (Québec) H3M 3A2
Phone : (514) 335-9922 | Fax : (514) 335-991919
Website : www.adaltis.com
2004 - 2007
AngioChem has the potential to become a leader in the field of Central Nervous System (CNS) disorders following the development of a technology platform allowing the delivery of drugs to the brain without breaking the integrity of the Blood-Brain Barrier. Short term, the company is developing innovative drugs to treat brain tumours but it is already anticipating addressing some numerous unmet medical needs for other diseases of the CNS.
141, President Kennedy Avenue Suite SB-5210 Montréal (Québec) H2X 3Y7
Phone : (514) 788-7800 | Fax : (514) 788-7801
Website : www.angiochem.com
Aurelium BioPharma inc.
1998 - 2003
An emerging company that uses functional proteomics to identify new targets for the treatment of multi-drug resistance in cancer.
8475, Christophe-Colomb Avenue Suite 1000 Montréal (Québec) H2M 2N9
Phone : (514) 384-6789 | Fax : (514) 384-365
Website : www.aureliumbiopharma.com
Bio-K Plus International inc.
1995 - 1999
Founded in 1994, this company markets a natural non-fat dairy product containing a high concentration of LactobacillusAcidophilus et Lb. Casei cultures on the U.S. and Canadian nutraceutical markets.
495, Armand-Frappier Blvd. Laval (Québec) H7V 4A7
Phone : (450) 978-2465 | Fax : (450) 978-9729
Website : www.biokplus.com
BioEnvelop Technologies inc.
1999 - 2002
Bioenvelopp was acquired in 2007 by Paladin Labs Inc. This company intends to position itself as a world leader in the design, manufacture and marketing of a biodegradable coating and packaging solutions of agri-food products. BioEnvelop holds the exclusive licence for this new technology, which was developed by Dr. Monique Lacroix of the INRS-Institut Armand-Frappier.
6111, Royalmount Ave, Suite 102 Montréal (Québec) H4P 2T4
Phone : (514) 340-1112 | Fax : (514)344-4675
Website : www.bioenvelop.com